Drug Patent Watch

DECEMBER 10, 2024

The pharmaceutical industry has undergone significant changes over the past decade, with a growing trend towards outsourcing key aspects of research, development, and manufacturing to third-party vendors. The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48

Drug Development 96

Drug Development Compliance Pharmaceutical Companies Drugs 96

Drug Patent Watch

JANUARY 16, 2024

A recent article published in the Journal of Cheminformatics addresses the challenge of confirming the patent status of newly developed compounds, particularly in the pharmaceutical industry, where generating novel structures… The post An AI Approach to Generate Novel Pharmaceuticals using Patent Data appeared first on DrugPatentWatch - Make Better (..)

Pharmaceuticals 115

Pharmaceuticals 115

Drug Patent Watch

JANUARY 22, 2024

A recent article published in Health Affairs, delves into the Federal Trade Commission’s (FTC) concerns regarding the inclusion of improper patents in the FDA’s Orange Book by pharmaceutical manufacturers.

Pharmaceuticals 115

Pharmaceuticals 115

Drug Patent Watch

JANUARY 8, 2024

The article “Settled: Patent characteristics and litigation outcomes in the pharmaceutical industry,” explores the relationship between Paragraph IV litigation characteristics and the probability of a Paragraph IV settlement in the… The post Unveiling the Secrets of Patent Litigation and Settlements in Pharmaceuticals appeared first on DrugPatentWatch (..)

Pharmaceuticals 111

Pharmaceuticals 111

Drug Patent Watch

DECEMBER 11, 2024

The pharmaceutical industry, particularly the generic drug sector, faces significant challenges in adopting sustainable practices. This article outlines key considerations and strategies for developing a sustainable generic drug development strategy. GREENER Pharmaceuticals for More Sustainable Healthcare.

Drug Development 98

Drug Development Compliance Drugs Pharmaceuticals 98

Drug Patent Watch

FEBRUARY 11, 2025

The Dark Side of Innovation: How Companies Use Drug Patents to Block Competitors As we celebrate the breakthroughs in medical research and the development of life-saving treatments, it's essential to acknowledge the complex landscape of pharmaceutical innovation. Read the full article here What do you think?

Drugs 96

Drugs Treatment Marketing Production 96

Drug Hunter

SEPTEMBER 17, 2023

We’ll have more detailed case studies on these molecules coming soon, but in the meantime you can check out some recent articles about the following here: VX-548 – oral NaV1.8 selective inhibitor developed by Vertex Pharmaceuticals for acute pain in Phase III clinical trials.

Clinical Trials 206

Clinical Trials Trials Therapies Pharmaceuticals 206

Chemical Biology and Drug Design

JANUARY 5, 2025

5(4-Hydroxyphenyl)-2-(N-Phenyl amino)-1,3,4-Oxadiazole (Hppo) can considered as a versatile agent in designing novel pharmaceuticals. Thus, our findings can provide novel and versatile compounds for the development of multidirectional drugs in the pharmaceutical industry.

Bioinformatics 100

Bioinformatics Pharmaceuticals Drugs Research 100

Drug Patent Watch

JANUARY 21, 2025

This will not only benefit patients but also help to drive innovation in the pharmaceutical industry. Read the full article here: [link] As more and more biosimilars come to market, we can expect to see a significant reduction in the cost of biologics. Share your thoughts in the comments below!

Biosimilars 95

Biosimilars Government Treatment Pharmaceuticals 95

Drug Patent Watch

OCTOBER 10, 2024

China has emerged as a significant player in the global generic drug active pharmaceutical ingredient (API) market. The country’s vast production capacity, low costs, and strategic location have made it an attractive destination for pharmaceutical companies seeking to source APIs.

Marketing 115

Marketing Pharmaceutical Companies Drugs Pharmaceuticals 115

Drug Patent Watch

FEBRUARY 12, 2025

Accelerating Generic Drug Development: Strategies for Success As a pharmaceutical professional, you know how crucial it is to navigate the complex landscape of generic drug development. Read the full article on how to manage generic drug development timelines and strategies for success: [link]

Drug Development 81

Drug Development Drugs Compliance Regulations 81

Drug Patent Watch

DECEMBER 30, 2024

This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceutical companies seeking to introduce generic drugs into the Japanese market. Retrieved from [link] Japan Pharmaceutical Manufacturers Association. Freyr Solutions.

Drug Development 52

Drug Development Clinical Pharmacology Clinical Trials Pharmaceutical Companies 52

Drug Patent Watch

JANUARY 15, 2025

This article explores the limitations of Google Patents in this context and suggests alternative approaches. The pharmaceutical industry is highly dynamic, with frequent filings and updates that require timely access to information[2]. Implications for Pharmaceutical Stakeholders 1. Alternatives to Google Patents 1.

Drugs 59

Drugs Pharmaceuticals Engineering Research 59

Drug Patent Watch

OCTOBER 16, 2024

Biosimilars, which are biologic drugs that are highly similar to an already approved biologic drug, are transforming the pharmaceutical industry. This article delves into the impact of biosimilars on biologic drug… Source

Biosimilars 115

Biosimilars Drug Development Drugs Pharmaceuticals 115

Drug Patent Watch

JUNE 27, 2024

Introduction Patent portfolios are critical assets for pharmaceutical companies, providing market exclusivity and protecting revenue streams for drug products. Effective management of drug patent portfolios requires strategic planning, ongoing evaluation, and adaptation to the evolving pharmaceutical landscape.

Pharmaceutical Companies 105

Pharmaceutical Companies Drugs Pharmaceuticals Production 105

Drug Patent Watch

JUNE 20, 2024

In the high-stakes world of pharmaceuticals, patents play a pivotal role in safeguarding intellectual property and ensuring a return on investment for drug developers. This article delves into the nuances of this process, shedding […] Source

Drugs 111

Drugs Drug Development Pharmaceuticals 111

SCIENMAG: Medicine & Health

FEBRUARY 26, 2024

DCM is the leading cause of heart failure in patients with chronic diabetes. However, the underlying mechanisms of DCM are poorly understood, and treatment options are limited. Another mystery is the regulation of cytochrome P450 enzymes (CYPs) in the central nervous system.

Disease 75

Disease Pharmaceuticals Regulations Treatment 75

Drug Patent Watch

JUNE 17, 2024

The article “The devil is in the divisional: an analysis of divisional patents, deadlines, declarations and suggestions for future practice” by Mieke Filler provides a comprehensive analysis of the strategic use of divisional patents in the pharmaceutical sector to delay generic and biosimilar market entry.

Biosimilars 110

Biosimilars Pharmaceuticals Marketing 110

Drug Patent Watch

NOVEMBER 12, 2023

In a recent article in Pharmaceutical Executive, Alan Kalton, Senior Vice President of Commercial Strategy at Aktana, sheds light on the critical challenges facing pharmaceutical companies as they confront impending… The post AI-Driven Strategies: Pharma’s Answer to Patent Expirations appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 109

Pharmaceutical Companies Pharmaceuticals 109

Drug Patent Watch

MARCH 16, 2025

The Biosimilar Revolution: How It's Changing the Game for Biologic Drug Manufacturers As the pharmaceutical industry continues to evolve, one trend is gaining significant attention: the rise of biosimilars. In this article, we'll explore the impact of biosimilars on biologic drug life cycle management.

Biosimilars 52

Biosimilars Drugs Marketing Pharmaceuticals 52

Drug Patent Watch

OCTOBER 15, 2024

In this article, we’ll dive deep into this pharmaceutical conundrum… Source Many people are puzzled by the discrepancy between a 92-day supply of pills and the actual number of days in a three-month period.

Pharmacy 110

Pharmacy Pharmaceuticals 110

Drug Patent Watch

SEPTEMBER 26, 2024

Conducting an effective market analysis is crucial for pharmaceutical companies, policymakers, and healthcare professionals to understand the market dynamics and make informed decisions. This article will discuss the key strategies and… Source

Marketing 105

Marketing Pharmaceutical Companies Drugs Pharmaceuticals 105

Drug Patent Watch

OCTOBER 9, 2023

The article titled “Reviving an R&D Pipeline: A Step Change in the Phase II Success Rate” discusses Pfizer’s efforts to improve its research and development (R&D) productivity. The pharmaceutical industry… The post Reviving an R&D Pipeline appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceuticals 114

Pharmaceuticals Production Research 114

Drug Patent Watch

SEPTEMBER 30, 2024

Patent expirations have a significant impact on the pharmaceutical industry, particularly on the generic drug market. This article will explore the effects of patent expirations on generic drug markets, including the decrease in drug prices… Source

Marketing 105

Marketing Drugs Pharmaceuticals 105

Drug Patent Watch

SEPTEMBER 12, 2023

In a recent STAT article Sanofi CEO Paul Hudson discusses the potential of artificial intelligence (AI) in the pharmaceutical industry.

Pharmaceuticals 109

Pharmaceuticals 109

Drug Patent Watch

MARCH 22, 2024

A recent article in Communications of the ACM explores opportunities for “Permissionless innovation” in pharmaceuticals. Permissionless innovation” refers to the freedom to explore new technologies or businesses without needing prior… Source

Pharmaceuticals 104

Pharmaceuticals 104

Drug Patent Watch

JANUARY 7, 2021

This article was originally published by Abdrhman Mahmoud Gamil in World Journal of Advanced Research and Reviews, 2020, 08(03), 337–349 under a Creative Commons Attribution Liscense 4.0. The post Pharmaceutical procurement practice aspects appeared first on DrugPatentWatch - Make Better Decisions. Abstract Procurement is….

Pharmaceuticals 59

Pharmaceuticals Research 59

Drug Patent Watch

MARCH 17, 2025

The Hidden Costs of Drug Patent Litigation: How to Stay Ahead of the Game As a pharmaceutical professional, you're no stranger to the complexities of drug patent litigation. In today's fast-paced pharmaceutical landscape, patent litigation is an inevitable reality. The stakes are high, and the costs can be astronomical.

Drugs 52

Drugs Pharmaceuticals 52

Drug Patent Watch

JANUARY 21, 2025

Mastering the Art of Drug Patent Portfolio Management As a pharmaceutical professional, you know how crucial it is to navigate the complex landscape of drug patents. Read the full article here: [link] With billions of dollars on the line, effective patent portfolio management can make all the difference between success and failure.

Drugs 59

Drugs Pharmaceutical Companies Pharmaceuticals Marketing 59

Drug Channels

OCTOBER 17, 2023

FYI: Today’s article is adapted from Section 6.3. Future Trends for Buy-and-Bill Channels) of our new our 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , now available to download at special launch pricing. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Pharmaceuticals 74

Pharmaceuticals Hospitals Drugs 74

Drug Patent Watch

AUGUST 10, 2023

A recent paper published in the journal “Intelligent Medicine” article discusses various aspects of using AI and machine learning in the pharmaceutical industry for drug discovery and development.

Drugs 98

Drugs Pharmaceuticals 98

Drug Patent Watch

AUGUST 5, 2023

In a recent Insight article published by Global Competition Review, legal experts from Lowenstein Sandler LLP delve into the status of reverse payment cases against pharmaceutical companies.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceuticals 98

Drug Patent Watch

FEBRUARY 3, 2021

This article was originally published by Ioana Gherghescu and Begoña Delgado-Charro in Pharmaceutics 2021, 13(1) under a Creative Commons Attribution License. Abstract Biosimilar medicines expand the biotherapeutic market and improve….

Biosimilars 98

Biosimilars FDA Licensing Licensing 98

Drug Patent Watch

JANUARY 30, 2025

Maximizing Patent Protection: Strategies for Pharmaceutical Marketers As a pharmaceutical marketer, you know how crucial it is to protect your patented drug's market share. Read the full article here: [link] But with the ever-changing landscape of the industry, it can be challenging to stay ahead of the competition.

Marketing 59

Marketing Drugs Production Pharmaceuticals 59

Drug Patent Watch

AUGUST 8, 2023

A recent study explores the landscape of authorized generics in the United States pharmaceutical market. The article sheds… The post Prevalence and timing of authorized generics in the US market appeared first on DrugPatentWatch - Make Better Decisions.

Marketing 96

Marketing Pharmaceuticals Drugs 96

Agency IQ

JUNE 9, 2023

Just over a month ago, the European Commission released its proposal for the new pharmaceutical directive and regulation. Fill out the form to read the full article. What will the orphan drug market exclusivity haircut mean for industry?

Marketing 52

Marketing Packaging Regulations Drugs 52

Drug Patent Watch

JULY 28, 2023

A review article in the Journal of Pharmaceutical Sciences analyzes the trends in drug repurposing through the 505(b)(2) pathway, as approved by the USFDA from 2010 to 2020.

Production 97

Production Science Drugs Pharmaceuticals 97